Brentuximab vedotin-induced pancreatitis in lymphoma: a pharmacovigilance study. Moore DC, Elmes JB, Strassels SA, Patel JN, et al. Leuk Lymphoma 2022 Mar 6:1-2. doi: 10.1080/10428194.2022.2045601.

Read + Share

Amedeo Smart

Independent Medical Education

Moore DC, Elmes JB, Strassels SA, Patel JN, et al. Brentuximab vedotin-induced pancreatitis in lymphoma: a pharmacovigilance study. Leuk Lymphoma 2022 Mar 6:1-2. doi: 10.1080/10428194.2022.2045601.
PMID: 35249444